The state Prescription Drug Affordability Board has drawn passionate opposition from patients with rare diseases who worry that the board’s actions could have unintended consequences.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
